6533b872fe1ef96bd12d4219
RESEARCH PRODUCT
Nanoparticle Assembly of Surface-Modified Proteins
Peter WichLydia RadiMatthias Fachsubject
Carrier systemCell SurvivalSurface PropertiesNanoparticleNanotechnology02 engineering and technology010402 general chemistry01 natural sciencesBiochemistryCatalysisStructure-Activity RelationshipColloid and Surface ChemistryProtein structureHumansDenaturation (biochemistry)Particle SizeSolubilityDrug CarriersDose-Response Relationship DrugChemistryGeneral Chemistry021001 nanoscience & nanotechnology0104 chemical sciencesDoxorubicinDrug deliveryBiophysicsPEGylationNanoparticlesMuramidase0210 nano-technologyHeLa CellsMacromoleculedescription
Nature's biomaterials such as peptides and proteins represent a valuable source of highly defined macromolecules. Herein we developed a nanoparticle drug delivery system based on the assembly of surface-modified proteins that can be transferred into organic solvents and represent the structural material of the carrier system. The particles are prepared by an oil-in-water nanoemulsion technique without the need of additional denaturation or cross-linking steps for stabilization. We achieve the necessary lipophilic solubility switch of the protein material by high surface PEGylation under conservation of the native three-dimensional protein structure. This study focuses on lysozyme as model enzyme for the preparation of empty and doxorubicin-loaded nanoparticles with an average diameter of 100 nm. The particles are stable in physiological buffers and only release their therapeutic payload into cancer cells after a time-dependent cellular uptake. We also transferred this approach to various proteins, exemplifying the universal applicability of our new preparation method for protein-based nanoparticles.
year | journal | country | edition | language |
---|---|---|---|---|
2016-08-17 | Journal of the American Chemical Society |